* Oscar Health Inc OSCR.N reported a quarterly adjusted
loss
of 22 cents per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -29 cents. The mean expectation of
seven analysts for the quarter was for a loss of 17 cents per
share. Wall Street expected results to range from -23 cents
to -5 cents per share.
* Revenue rose 68.3% to $2.42 billion from a year ago;
analysts
expected $2.34 billion.
* Oscar Health Inc's reported EPS for the quarter was a loss
of 22
cents.
* The company reported a quarterly loss of $54.6 million.
* Oscar Health Inc shares had fallen by 26.7% this
quarter and
gained 69.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 9% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the life & health
insurance peer group is also "buy"
Wall Street's median 12-month price target for Oscar Health Inc
is $27.50
This summary was machine generated from LSEG data November 7 at
02:46 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.17 -0.22 Missed
Jun. 30 2024 0.16 0.20 Beat
Mar. 31 2024 0.27 0.62 Beat
Dec. 31 2023 -0.72 -0.66 Beat